Intel Corporation (INTC - Free Report) , is one of the world's largest semiconductor chip makers. With Growth and VGM scores of ‘A’, this company’s Q1 2018 results benefited from robust data-centric growth. Lower spending helped expand profit margins. Management raised its 2018 guidance, based on solid growth trends. Shares have outperformed the industry on a year-to-date basis. It also pays a good dividend.
Noodles & Company (NDLS - Free Report) , is a fast casual restaurant which offers lunch and dinner. Company Q1 revenues surpassed the Zacks Consensus Estimate. Company shares have rallied significantly in the past year. The company has been closing its underperforming restaurants, which has positively impacted its margins.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Intel Corporation (INTC - Free Report) , is one of the world's largest semiconductor chip makers. With Growth and VGM scores of ‘A’, this company’s Q1 2018 results benefited from robust data-centric growth. Lower spending helped expand profit margins. Management raised its 2018 guidance, based on solid growth trends. Shares have outperformed the industry on a year-to-date basis. It also pays a good dividend.
Noodles & Company (NDLS - Free Report) , is a fast casual restaurant which offers lunch and dinner. Company Q1 revenues surpassed the Zacks Consensus Estimate. Company shares have rallied significantly in the past year. The company has been closing its underperforming restaurants, which has positively impacted its margins.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on INTC - FREE
Get the latest research report on NDLS - FREE